Dr. Soliman Abdel Kader Fakeeh Hospital Co. (4017) is listed on Tadawul under the Health Care Equipment & Svc sector. In fiscal year 2025, the company reported revenue of SAR 3.09B, net profit of SAR 248M, and earnings per share of SAR 1.26. The stock trades at a P/E ratio of 28.6. All figures sourced from the official CMA-mandated XBRL filing dated 2025-12-31.
Dr. Soliman Abdel Kader Fakeeh Hospital Co. (4017) is listed on Tadawul of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).
For fiscal year 2025, Dr. Soliman Abdel Kader Fakeeh Hospital Co. reported revenue of SAR 3.09B, net profit of SAR 248M, and earnings per share of SAR 1.26. Total assets stood at SAR 5.83B with total equity of SAR 3.17B and total liabilities of SAR 2.25B.
Operating cash flow for 2025 was SAR 454M, representing a cash conversion ratio of 1.83 relative to net profit. Free cash flow was SAR -161M.
Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2025, SAR 1.83 arrived as operating cash. This indicates Exceptional quality earnings based on the cash conversion ratio of 1.83.
Key financial ratios for 2025: Return on Equity 7.8%, Return on Assets 4.3%, Net Margin 8.0%, Debt to Equity 0.71.
Loading...